Vanta vs. Drata vs. OneTrust: HIPAA Automation for AI Health ROI
Expert Opinions

HIPAA-Compliant AI: Scoring Frameworks for Health Plans

Listen to this article · 7 min listen

The proliferation of artificial intelligence across healthcare promises transformative efficiencies and improved patient outcomes. However, for health plans and large employers, the integration of AI health tools is not merely about innovation; it is fundamentally about trust and compliance. The critical question facing Health Plan Executives and HR leaders today is: How do we rigorously evaluate AI health vendors to ensure they meet the stringent requirements of HIPAA, safeguarding protected health information (PHI) while delivering on their clinical promises? This demands a sophisticated, structured scoring framework that goes beyond superficial claims.

Establishing a Robust Vendor Evaluation Framework

Health plans are increasingly adopting structured scoring frameworks to assess AI health tools, recognizing that a vendor’s technical prowess must be matched by an unassailable compliance posture. This approach acts as an essential enterprise procurement filter, ensuring that any AI solution integrated into care pathways adheres to the highest standards of data privacy and security. Companies like Vanta and Drata, while not direct AI health providers, play a crucial role in this ecosystem by offering automated compliance platforms that can help AI health vendors demonstrate their adherence to security standards, including aspects relevant to HIPAA. This third-party validation provides a layer of assurance for health plans performing due diligence. When examining specific AI health apps, a clear differentiation emerges. For instance, companies like Omada Health and Hinge Health, which offer digital chronic disease management and musculoskeletal care respectively, typically operate within well-defined regulatory boundaries, often engaging directly with health plans and employers. Their business models necessitate robust HIPAA compliance, encompassing the HIPAA Privacy Rule, HIPAA Security Rule, and HIPAA Breach Notification Rule. These organizations generally understand the imperative of securing PHI and often pursue certifications and attestations that align with health plan expectations. Conversely, the landscape becomes more complex with platforms like BetterHelp and Hims & Hers. While providing valuable services, their historical data practices have sometimes raised red flags. For example, BetterHelp faced scrutiny and a 2023 FTC settlement regarding its advertising practices from 2017-2020, which involved sharing certain user data for advertising optimization. While BetterHelp maintains that private therapeutic information was not shared, the settlement required a $7.8 million penalty and mandated express affirmative consent for future data disclosures for advertising purposes. This highlights a critical relationship: such past data practices, even if not involving clinical data, can raise significant concerns for health plans and employers regarding trust and compliance benchmarks set by more integrated digital health solutions. Since the settlement, BetterHelp has implemented enhanced privacy measures and achieved HITRUST certification. This distinction is paramount for Health Plan Executives and Employers/HR, as a single misstep in data handling can have profound repercussions, both regulatory and reputational. The insights from figures like Deven McGraw, a recognized authority in health privacy and security, underscore the necessity of this rigorous evaluation. Her work consistently emphasizes that compliance is not a static state but an ongoing commitment to protecting sensitive health data. Similarly, the perspectives of Karen DeSalvo, with her background in health information technology, reinforce the need for interoperability and secure data exchange within a compliant framework. Christine Bechtel further champions the patient’s perspective, emphasizing that trust is built on transparent and secure data practices. These expert voices collectively advocate for a proactive, comprehensive approach to vendor assessment, moving beyond mere declarations of compliance to verifiable, auditable processes.

Navigating the Regulatory Landscape for AI Health

The regulatory environment for AI in healthcare is multifaceted, demanding careful consideration from health plans. The foundational pillars remain the HIPAA Privacy Rule, which sets standards for the use and disclosure of PHI, and the HIPAA Security Rule, which mandates administrative, physical, and technical safeguards to protect electronic PHI. The HIPAA Breach Notification Rule further requires covered entities and business associates to provide notification following a breach of unsecured PHI. These rules form the bedrock of any AI health compliance checklist. Beyond HIPAA, the Office of the National Coordinator for Health Information Technology (ONC) plays a pivotal role, particularly with initiatives like ONC HTI-2 (Health Data, Technology, and Interoperability: Trusted Exchange Framework and Common Agreement). The HTI-2 final rule, published in December 2024 and effective January 15, 2025, primarily focuses on establishing federal regulations for the Trusted Exchange Framework and Common Agreement (TEFCA) to enhance nationwide interoperability, privacy, security, and trust in health information exchange. While promoting interoperability is crucial for integrating AI tools securely and effectively ONC HTI-2 final rule details, some broader proposals related to AI algorithm transparency from the initial HTI-2 proposed rule were not finalized. Health plans must still ensure that AI vendors can demonstrate how their algorithms function, how they are trained, and how potential biases are mitigated, aligning with general transparency requirements and best practices for responsible AI deployment. The enforcement arm, the HHS Office for Civil Rights (HHS OCR), is the primary agency responsible for enforcing HIPAA, and its actions serve as a constant reminder of the consequences of non-compliance. Health plans must consider the potential for OCR investigations and penalties when evaluating vendors. Furthermore, organizations like the National Committee for Quality Assurance (NCQA) provide accreditation and certification programs that often incorporate data security and privacy standards, serving as additional benchmarks for health plans to consider in their vendor evaluation frameworks. NCQA’s focus on quality improvement often intersects with the responsible deployment of technology, including AI NCQA digital health standards. For highly specialized AI applications, such as those offered by Tempus AI in precision medicine and oncology, the integration with clinical workflows and sensitive genomic data necessitates an even higher bar for compliance. Their engagement often involves sophisticated data warehousing and analytical capabilities, requiring robust adherence to all aspects of HIPAA and potentially other research-specific regulations. The complexity of these data environments underscores why basic compliance certifications are merely a starting point, not an endpoint, for comprehensive vendor assessment.

The Imperative of Proactive Due Diligence

For Health Plan Executives and Employers/HR, the message is clear: proactive, in-depth due diligence is non-negotiable when procuring AI health tools. Relying solely on a vendor’s self-attestation of HIPAA compliance is insufficient. A robust vendor evaluation framework must scrutinize a vendor’s data governance policies, technical safeguards, and breach response plans. It should include detailed compliance checklists and leverage vendor evaluation frameworks that benchmark against established standards and best practices. The consequences of failing to adequately vet AI health vendors can range from significant financial penalties imposed by HHS OCR to severe reputational damage and erosion of member trust. The digital health landscape is evolving rapidly, with AI workflow regulations in healthcare becoming increasingly stringent. As such, health plans must continuously refine their procurement filters, ensuring that only HIPAA compliant AI health apps that demonstrate an unwavering commitment to data privacy and security are integrated into their ecosystems. This strategic approach not only protects PHI but also fosters innovation within a secure and trustworthy environment, ultimately benefiting members and the broader healthcare system.

Frequently Asked Questions

What is the primary concern for health plans and employers when integrating AI health tools?

The primary concern is ensuring that AI health vendors meet HIPAA’s stringent requirements for safeguarding protected health information (PHI) while also delivering on clinical promises. This involves balancing innovation with trust and compliance to protect sensitive patient data.

How can health plans and employers rigorously evaluate AI health vendors for compliance?

They can establish robust, structured scoring frameworks that go beyond superficial claims. This includes assessing a vendor’s technical prowess alongside their compliance posture, often utilizing third-party validation platforms like Vanta or Drata to demonstrate adherence to security standards relevant to HIPAA.

What specific HIPAA rules are most relevant when evaluating AI health tools?

The most relevant HIPAA rules are the HIPAA Privacy Rule, which sets standards for PHI use and disclosure; the HIPAA Security Rule, mandating safeguards for electronic PHI; and the HIPAA Breach Notification Rule, requiring notification following a breach of unsecured PHI. These form the foundation of any compliance checklist.

Why is past data handling, even if not involving clinical data, a concern for health plans and employers?

Past data practices, such as those that led to the BetterHelp FTC settlement regarding advertising optimization, can raise significant concerns about trust and compliance benchmarks. A single misstep in data handling can have profound regulatory and reputational repercussions for health plans and employers, even if clinical data was not directly shared.

Share
Was this article helpful?

Michael Davis

Michael, a health policy analyst, provides thoughtful Opinion & Analysis on current health debates. His work challenges perspectives and fosters informed discussion.